Celcuity (CELC) Competitors $52.42 +2.04 (+4.05%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$51.58 -0.84 (-1.61%) As of 08/22/2025 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CELC vs. GH, OPCH, RDNT, SHC, BTSG, SGRY, WGS, CON, PRVA, and VCYTShould you be buying Celcuity stock or one of its competitors? The main competitors of Celcuity include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), BrightSpring Health Services (BTSG), Surgery Partners (SGRY), GeneDx (WGS), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. Celcuity vs. Its Competitors Guardant Health Option Care Health RadNet Sotera Health BrightSpring Health Services Surgery Partners GeneDx Concentra Group Holdings Parent Privia Health Group Veracyte Guardant Health (NASDAQ:GH) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk, media sentiment and institutional ownership. Is GH or CELC more profitable? Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -49.93%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.Company Net Margins Return on Equity Return on Assets Guardant Health-49.93% N/A -28.95% Celcuity N/A -150.07%-64.67% Does the media prefer GH or CELC? In the previous week, Guardant Health had 1 more articles in the media than Celcuity. MarketBeat recorded 9 mentions for Guardant Health and 8 mentions for Celcuity. Guardant Health's average media sentiment score of 1.11 beat Celcuity's score of 0.29 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Celcuity 1 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, GH or CELC? Guardant Health has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Which has stronger earnings and valuation, GH or CELC? Celcuity has lower revenue, but higher earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGuardant Health$828.85M9.24-$436.37M-$3.35-18.33CelcuityN/AN/A-$111.78M-$3.45-15.19 Do insiders & institutionals have more ownership in GH or CELC? 92.6% of Guardant Health shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 6.1% of Guardant Health shares are held by insiders. Comparatively, 15.8% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Do analysts prefer GH or CELC? Guardant Health presently has a consensus price target of $57.50, indicating a potential downside of 6.35%. Celcuity has a consensus price target of $50.60, indicating a potential downside of 3.47%. Given Celcuity's higher possible upside, analysts clearly believe Celcuity is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Guardant Health 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 1 Strong Buy rating(s) 3.06Celcuity 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryGuardant Health beats Celcuity on 11 of the 16 factors compared between the two stocks. Get Celcuity News Delivered to You Automatically Sign up to receive the latest news and ratings for CELC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CELC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CELC vs. The Competition Export to ExcelMetricCelcuityMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.14B$3.11B$5.76B$9.58BDividend YieldN/A2.23%4.41%4.10%P/E Ratio-15.1920.8831.1026.04Price / SalesN/A343.33433.45102.77Price / CashN/A43.1937.7358.48Price / Book49.928.129.536.61Net Income-$111.78M-$54.72M$3.26B$265.56M7 Day Performance1.22%2.63%2.10%1.97%1 Month Performance273.10%2.78%2.81%-0.36%1 Year Performance202.13%11.01%30.56%19.03% Celcuity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CELCCelcuity1.174 of 5 stars$52.42+4.0%$50.60-3.5%+210.5%$2.14BN/A-15.1940Short Interest ↑GHGuardant Health3.2374 of 5 stars$54.80+1.1%$57.50+4.9%+120.3%$6.76B$739.02M-16.362,021News CoveragePositive NewsOPCHOption Care Health4.556 of 5 stars$27.85-1.2%$35.75+28.4%-7.5%$4.58B$5.00B22.288,088News CoveragePositive NewsInsider TradeGap UpRDNTRadNet3.2944 of 5 stars$62.00+16.2%$69.60+12.3%+9.4%$4.00B$1.83B-144.1811,021News CoverageInsider TradeHigh Trading VolumeSHCSotera Health1.397 of 5 stars$14.06+0.6%$16.00+13.8%+8.2%$3.97B$1.10B175.773,000News CoverageHigh Trading VolumeBTSGBrightSpring Health Services1.6991 of 5 stars$20.66-0.6%$25.67+24.2%+107.8%$3.68B$11.27B66.6535,000Positive NewsSGRYSurgery Partners3.0154 of 5 stars$22.74-3.8%$33.00+45.1%-17.5%$3.03B$3.11B-15.9015,000News CoverageWGSGeneDx2.216 of 5 stars$110.54+5.1%$101.63-8.1%+278.2%$3.02B$305.45M2,210.801,200Positive NewsInsider TradeCONConcentra Group Holdings Parent2.3451 of 5 stars$21.47-0.7%$28.50+32.7%+2.2%$2.77B$1.90B18.0411,250News CoveragePositive NewsPRVAPrivia Health Group4.2814 of 5 stars$20.31-1.3%$28.00+37.9%+9.9%$2.53B$1.74B184.651,140News CoveragePositive NewsAnalyst UpgradeVCYTVeracyte2.8427 of 5 stars$27.99+2.3%$40.90+46.1%-0.2%$2.15B$445.76M84.82790News Coverage Related Companies and Tools Related Companies Guardant Health Competitors Option Care Health Competitors RadNet Competitors Sotera Health Competitors BrightSpring Health Services Competitors Surgery Partners Competitors GeneDx Competitors Concentra Group Holdings Parent Competitors Privia Health Group Competitors Veracyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CELC) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celcuity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Celcuity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access